Works matching IS 10837159 AND DT 2023 AND VI 28 AND IP 2
Results: 16
Persisting Gaps in Optimal Care of Stage III Non-small Cell Lung Cancer: An Australian Patterns of Care Analysis.
- Published in:
- Oncologist, 2023, v. 28, n. 2, p. e92, doi. 10.1093/oncolo/oyac246
- By:
- Publication type:
- Article
Comprehensive Landscape of Cyclin Pathway Gene Alterations and Co-occurrence with FGF/FGFR Aberrations Across Urinary Tract Tumors.
- Published in:
- Oncologist, 2023, v. 28, n. 2, p. e82, doi. 10.1093/oncolo/oyac180
- By:
- Publication type:
- Article
Bintrafusp Alfa: A Bifunctional Fusion Protein Targeting PD-L1 and TGF-β, in Patients with Pretreated Colorectal Cancer: Results from a Phase I Trial.
- Published in:
- Oncologist, 2023, v. 28, n. 2, p. e124, doi. 10.1093/oncolo/oyac254
- By:
- Publication type:
- Article
Phase Ib Study of Ulixertinib Plus Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Adenocarcinoma.
- Published in:
- Oncologist, 2023, v. 28, n. 2, p. e115, doi. 10.1093/oncolo/oyac237
- By:
- Publication type:
- Article
The Value of Phenotypic Precision Medicine in Prostate Cancer.
- Published in:
- Oncologist, 2023, v. 28, n. 2, p. 93, doi. 10.1093/oncolo/oyac198
- By:
- Publication type:
- Article
Efficacy and Safety of Avapritinib in Treating Unresectable or Metastatic Gastrointestinal Stromal Tumors: A Phase I/II, Open-Label, Multicenter Study.
- Published in:
- Oncologist, 2023, v. 28, n. 2, p. 187, doi. 10.1093/oncolo/oyac242
- By:
- Publication type:
- Article
Palliative Rehabilitation in Acute Inpatient Rehabilitation: Prognostic Factors and Functional Outcomes in Patients with Cancer.
- Published in:
- Oncologist, 2023, v. 28, n. 2, p. 180, doi. 10.1093/oncolo/oyac229
- By:
- Publication type:
- Article
Clinical Implications and Treatment Strategies for ESR1 Fusions in Hormone Receptor-Positive Metastatic Breast Cancer: A Case Series.
- Published in:
- Oncologist, 2023, v. 28, n. 2, p. 172, doi. 10.1093/oncolo/oyac248
- By:
- Publication type:
- Article
The Use of Natural Language Processing to Assess Social Support in Patients With Advanced Cancer.
- Published in:
- Oncologist, 2023, v. 28, n. 2, p. 165, doi. 10.1093/oncolo/oyac238
- By:
- Publication type:
- Article
Comparative Effectiveness of Front-Line Ipilimumab and Nivolumab or Axitinib and Pembrolizumab in Metastatic Clear Cell Renal Cell Carcinoma.
- Published in:
- Oncologist, 2023, v. 28, n. 2, p. 157, doi. 10.1093/oncolo/oyac195
- By:
- Publication type:
- Article
Five-Year Prospective Observational Study of African-American Men on Active Surveillance for Prostate Cancer Demonstrates Race Is Not Predictive of Oncologic Outcomes.
- Published in:
- Oncologist, 2023, v. 28, n. 2, p. 149, doi. 10.1093/oncolo/oyac154
- By:
- Publication type:
- Article
Tumor Growth Rate Informs Treatment Efficacy in Metastatic Pancreatic Adenocarcinoma: Application of a Growth and Regression Model to Pivotal Trial and Real-World Data.
- Published in:
- Oncologist, 2023, v. 28, n. 2, p. 139, doi. 10.1093/oncolo/oyac217
- By:
- Publication type:
- Article
Associations Between Race/Ethnicity, Language, and Enrollment on Cancer Research Studies.
- Published in:
- Oncologist, 2023, v. 28, n. 2, p. 131, doi. 10.1093/oncolo/oyac218
- By:
- Publication type:
- Article
Using the HER2/CEP17 FISH Ratio to Predict Pathologic Complete Response Following Neoadjuvant Anti-HER2 Doublet Therapy in HER2+ Breast Cancer.
- Published in:
- Oncologist, 2023, v. 28, n. 2, p. 123, doi. 10.1093/oncolo/oyac247
- By:
- Publication type:
- Article
Racial/Ethnic Differences Among Tumor-Infiltrating Lymphocytes in Breast Cancer Tumors.
- Published in:
- Oncologist, 2023, v. 28, n. 2, p. 116, doi. 10.1093/oncolo/oyac239
- By:
- Publication type:
- Article
A Systematic Review of Decision Aids in Hematologic Malignancies: What Are Currently Available and What Are We Missing?
- Published in:
- Oncologist, 2023, v. 28, n. 2, p. 105, doi. 10.1093/oncolo/oyac231
- By:
- Publication type:
- Article